Health
Tianlong's New Launch Gentier X3 Made its Appearance at Medlab Middle East 2024
DUBAI, UAE, Feb. 8, 2024 /PRNewswire/ -- The 4-day Medlab Middle East 2024 at the Dubai World Trade Center came to an end successfully onFebruary 8. MedLab is the largest exhibition of medical equipment in theMiddle East region, attracting visitors worldwide to experience the academic atmosphere ...
2024-02-08 21:00
3098
DKSH Hong Kong Business Unit Healthcare Solidifies Long-Term Partnership with Church & Dwight
DKSH Hong Kong Business Unit Healthcare renews its partnership with Church & Dwight. DKSH continues to provide full agency services with the aim to expand the reach of Church & Dwight's Anusol product range inHong Kong. This collaboration demonstrates DKSH's unwavering commitment to "Healthcare f...
2024-02-08 19:38
3096
New SANOIN Study Findings show Significant Rise in Hb levels in 14 days, Symptom Relief in 30 days & Improved Quality of life in women with Iron Deficiency Anemia
* SANOIN clinical study supported by P&G Health demonstrates efficacy of iron supplementation (ferrous gluconate + multivitamin & minerals) in improving Hb levels & Quality of life with demonstrated symptom relief * With 1 in 4 people suffering from Iron Deficiency Anemia in Southeast Asia, f...
2024-02-08 11:00
2492
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
MELBOURNE, Australia , Feb. 8, 2024 /PRNewswire/ --.Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). QSAM is a United...
2024-02-08 06:11
2174
SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer inSpain BOSTON and ROLLE, Switzerland and MADRID, Feb. 7, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, t...
2024-02-07 20:39
2323
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
ROCKVILLE, Md. and SUZHOU, China, Feb. 7, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2024-02-07 16:35
4670
MGI and ADK Trading and Shipping Forge Partnership to Bring Genomics Products to ADK Hospital in the Maldives
DUBAI, UAE, Feb. 7, 2024 /PRNewswire/ -- MGI Tech, a company committed to building core tools and technology to lead life science, today announced the signing of a sales agreement with ADK Trading and Shipping at Medlab Middle East 2024. The agreement includes the installation of mid-low throughp...
2024-02-07 14:51
1986
The Results of Phase II Clinical Study of KN046 in Combination with Nab-paclitaxel in TNBC were Published in Nature Communications
SUZHOU, China, Feb. 6, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the phase Ⅱclinical research results of anti- PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel as first-line treatment in advanced triple-negative breast cancer (TNBC) were ...
2024-02-07 09:50
1906
SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field
TOKYO, Feb. 7, 2024 /PRNewswire/ -- SMC Laboratories, Inc. ("SMC Laboratories"), a non-clinical contract research organization (CRO) that provides consulting and contract services for pharmacology studies utilizing technology and know-how related to Metabolic dysfunction associated steatohepatit...
2024-02-07 02:00
1674
SMC Laboratories Reveals Innovative STAM™-HCC/IO+ Mouse for Identifying and Developing Novel Therapeutic Drugs for Liver Cancer, Blazing a Trail in the Immuno-Oncology Field
TOKYO, Feb. 7, 2024 /PRNewswire/ -- SMC Laboratories, Inc. ("SMC Laboratories"), a non-clinical contract research organization (CRO) that provides consulting and contract services for pharmacology studies utilizing technology and know-how related toMetabolic dysfunction associated steatohepatiti...
2024-02-07 02:00
1738
ShiraTronics Completes Australian Pilot Study Enrollment; Prepares for Pivotal Clinical Study
MINNEAPOLIS, Feb. 7, 2024 /PRNewswire/ -- ShiraTronics, Inc., a pioneering
clinical-stage medical device company, today proudly announced the successful
conclusion of enrollment in their pilot study conducted inAustralia for their
minimally invasive, implantable migraine therapy.
2024-02-06 23:12
1634
Chamlion to showcase latest dental technology at AEEDC exhibition
NANJING, China, Feb. 6, 2024 /PRNewswire/ -- Chamlion will be showcasing its latest dental technology on the upcoming AEEDC exhibition (6th, Feb-8th Feb, Dubai). This is the first time that Chamlion is attending the show, and it is excited to introduce its products and services to all the visitor...
2024-02-06 20:11
1778
Cathay Life Insurance Co., Ltd. Triumphs at the International Innovation Awards 2023
SINGAPORE, Feb. 5, 2024 /PRNewswire/ -- Regional NGO Enterprise Asia hosted the International Innovation Awards (IIA) 2023 inTaipei, Taiwan, where 34 noteworthy innovations were celebrated for their significant impact on global industries and enhancement of the human experience. Preceding the awa...
2024-02-06 15:41
1905
Zuellig Pharma to Rollout the Volvo FE Electric truck for cold chain logistics
TAIPEI, Feb. 6, 2024 /PRNewswire/ -- The signing ceremony between Taikoo Motors, Zuellig Pharma, and Long Feng Medical Logistics confirmed the first delivery of a Volvo FE Electric truck for cold chain logistics inTaiwan, marking their partnership in promoting green transportation and heralding a...
2024-02-06 10:20
8783
Nordic Bioscience to make its precision medicine biomarker PRO-C3 available in China for research use only (RUO) in the first quarter of 2024.
HERLEV, Denmark, Feb. 6, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, today announced that the company's extracellular matrix (ECM) biomarker, PRO-C3 (nordicPRO-C3™) will be available as a research use only (RUO) product inChina at LabCorp. All testing outside China contin...
2024-02-06 06:30
1655
TraceLink's 2023 Success: Expanded Digitalization Capabilities and Growing Adoption of New Supply Chain Solutions
BOSTON, Feb. 6, 2024 /PRNewswire/ -- TraceLink, the world's largest digital network platform for healthcare and life sciences, expanded its digitalization capabilities in 2023, leading to an annual increase of more than 300 new customers. Utilizing the industry's largest integrated digital networ...
2024-02-06 04:50
1443
Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval
HANGZHOU, China, Feb. 5, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies inChina, announced today that, VenusP-Valve, the company's in-house developed innovative transcatheter pulmonic valve replaceme...
2024-02-05 21:00
2107
International Human Frontier Science Program Organization Releases 2024-2032 Strategic Plan: "Frontier Life Science in a Time of Change"
STRASBOURG, France, Feb. 5, 2024 /PRNewswire/ -- The International Human Frontier Science Program Organization (HFSPO) issued today its new, nine-year strategic plan which will greatly enhance Research Grant and Fellowship award programs and implement new initiatives to extend opportunities to mo...
2024-02-05 21:00
1707
Personnel changes in the Exyte management: Mark Garvey and Elena Bashkeeva are welcomed as new members of the Executive Board
* High-tech industry expert Mark Garvey is new Segment CEO for Exyte's Global Business Unit Advanced Technology Facilities * Elena Bashkeeva will become CFO at Exyte starting April 1st 2024 and will lead the Finance and Controlling functions as well as IT STUTTGART, Germany, Feb. 5, 2024 /PRN...
2024-02-05 20:00
1803
Luye Pharma Grants Myung In Pharm Exclusive Rights to Commercialize Rivastigmine Twice Weekly Transdermal Patch in South Korea
YANTAI, China, Feb. 5, 2024 /PRNewswire/ -- Luye Pharma Group has entered into an agreement with Myung In Pharm, granting the latter the exclusive rights to commercialize Rivastigmine Twice Weekly Transdermal Patch inSouth Korea. Developed by Luye Pharma, this drug is used to treat mild to modera...
2024-02-05 18:53
2735
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 314 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
2024-11-20 16:30
8005
Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
2024-11-20 09:00
7400